{"id":"W2158890671","doi":"10.1158/1078-0432.ccr-07-1416","title":"A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Adverse effect; Toxicity; Internal medicine; Nausea; Pharmacokinetics; Cancer; Tumor necrosis factor alpha; Gastroenterology; Monoclonal antibody; Pharmacology; Oncology; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001107725,0.001457063,0.001686393,0.0003494368,0.0004168864,0.0007102523,0.0007163802,0.0009885908,0.002473058],"category_scores_gemma":[0.0008791261,0.0005749369,0.0008824248,0.0003410324,0.0008613212,0.0007142509,0.0003158157,0.002100912,0.0006924196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008061259,"about_ca_system_score_gemma":0.001429662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005457763,"about_ca_topic_score_gemma":0.001363161,"domain_scores_codex":[0.9996439,0.0001653406,0.00001634711,0.0000663462,0.00003664016,0.00007147389],"domain_scores_gemma":[0.9994208,0.00009279694,0.0001197153,0.00003959325,0.00003556299,0.0002916575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6197147,0.08668946,0.01943957,0.00154639,0.001289615,0.001483857,0.0007594306,0.005642741,0.09041057,0.0003938345,0.007484308,0.1651455],"study_design_scores_gemma":[0.4662754,0.5006015,0.02179649,0.00003335726,0.0003017715,0.0009016508,0.00005584783,0.001436338,0.005055679,0.0001619238,0.003349215,0.00003088213],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947654,0.001553872,0.0004076095,0.0002785331,0.00006669855,0.001456544,0.0004551126,0.00005796286,0.0009583168],"genre_scores_gemma":[0.9917397,0.00152083,0.00131368,0.0006101216,0.0001557502,0.001571228,0.001668789,0.00002136254,0.001398604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002473058,"threshold_uncertainty_score":0.008273184,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1057952036680042,"score_gpt":0.4970493390645815,"score_spread":0.3912541353965774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}